Chairpersons: Tina Alster, MD; Joseph Jorizzo, MD; Faculty: C. William Hanke, MD, MPH, FACP; Susan Weinkle, MD; Wm. Philip Werschler, MD, FAAD
DisclosuresRelease Date: September 30, 2004;
Valid for credit through September 30, 2005 This activity has expired.
CME in this activity indicates that it was developed according to ACCME guidelines and was certified for credit by one or more accredited CME or CE providers. Medscape cannot attest to the timeliness of expired CME activities.
This CME activity is based on transcripts and slides of presentations as delivered by the faculty at the "The Aging Face: More Than Skin Deep" symposium held at the Hilton New York Hotel in New York, New York on July 28, 2004.
Editor's Note: When this symposium was held, the approval of poly-L-lactic acid was still pending with the United States Food and Drug Administration (FDA). Injectable poly-L-lactic acid (
Sculptra) now has been approved by the FDA for the "restoration and/or correction of the signs of facial fat loss (lipoatrophy) in people with human immunodeficiency virus."
Dermik Aesthetics is a new group within Dermik Laboratories.
